ThermoGenesis Holdings Inc. (THMO): Net earnings per share (EPS TTM)

ThermoGenesis (THMO) - corporate logo

A liquidity crisis and strategic uncertainty are hindering software monetization, as evidenced by ThermoGenesis (THMO) TTM net income per share distribution. The value of -4.72 indicates the level of this metric. However, its status as a standard in cell therapy allows ThermoGenesis (THMO) to exercise pricing power over its equipment. An impeccable B2B image and the trust of the scientific community solidify the brand's position within the biobanking sector.

ThermoGenesis (THMO) - Earnings per share for the trailing year from 07/04/2022 to 08/04/2024

Analytical breakdowns and data insights for company ThermoGenesis Holdings, Inc. (THMO)

- stock price and consensus target price:
Stock Price ThermoGenesis|THMO - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization ThermoGenesis Holdings|THMO - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share ThermoGenesis|THMO - Accounting Value of Company|Market Value to Book Value Ratio thermogenesis.com|THMO - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital ThermoGenesis|THMO - Long-Term Liabilities to Capital|Short-Term Debt to Capital ThermoGenesis Holdings Inc.|THMO - Company Aggregate Debt|Debts to Book Capitalization ThermoGenesis Holdings|THMO - Long-Term Debt Volume|Company Short-Term Debts ThermoGenesis|Quick Ratio thermogenesis.com
- earnings and valuation multiples indicators:
THMO - Net Profit|Expected Profit ThermoGenesis|THMO - Price to Earnings Ratio|Projected Price to Earnings ThermoGenesis Holdings|THMO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple ThermoGenesis Holdings|THMO - Profit before interest, taxes and amortization|Earnings per share for the last twelve months ThermoGenesis|THMO - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months thermogenesis.com|THMO - Earnings growth in current year|Earnings growth forecast for next year ThermoGenesis
Fundamental valuation:ThermoGenesis (THMO)
Manufactured products of ThermoGenesis Holdings, Inc.

ThermoGenesis is scaling B2B implementation of biobanking and cell culture systems to expand into the diagnostics segment. The TTM net income per share, equal to -4.72, measures the portion of profit allocated to each common share over the year. This metric strips out the influence of capital structure, allowing for an assessment of the business's actual efficiency. The TTM net income per share trend reflects the company's reaction to structural market shifts, which determines the fundamental stability of the asset's current market value.

Competitors of ThermoGenesis

Abbott Laboratories - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters thermofisher.com TMO|GEHC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Mettler-Toledo|Net earnings per share for the last 12 months WAT|TECH: Earnings per share for the trailing year|Earnings per share for the last twelve months Bruker Corporation (BRKR)|Net earnings per share for the last 12 months azenta.com AZTA|Net earnings per share (EPS TTM) VREX (Varex Imaging Corporation)|Semler Scientific Inc (SMLR) - Net earnings per one share for the last twelve months|Butterfly iQ - Net earnings per share (EPS TTM)|MLAB (Mesa Laboratories Corp.) - Earnings per share for the last 12 months|QSI: Net earnings per share (EPS TTM)|NNOX - Net earnings per share for the last four quarters|QTRX (Quanterix) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months 908 Devices Inc (MASS)|Net earnings per share (EPS TTM) CV|Net earnings per share (EPS TTM) MaxCyte Inc (MXCT)|Earnings per share for the last twelve months Rapid Micro Biosystems, Inc. RPID|seer.bio - Earnings per share for the last twelve months|HYPR: Net earnings per share for the last 12 months|Earnings per share for the trailing year FONR (FONAR Corp.)|DXR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Spectral AI Inc. (MDAI)|Earnings per share for the last twelve months VivoSim Labs|ACON - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (Akoya Biosciences)|Net earnings per share (EPS TTM) talis.bio (TLIS)|Net earnings per share (EPS TTM) TTOO (T2 Biosystems, Inc)